Incyte (INCY) Net Shares Issued and Repurchased (2010 - 2022)
Powered by 
Analysis
Incyte (INCY) Net Shares Issued and Repurchased (2010 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.65 Bn | 21.11 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 433,634.00 |
| Dec 31, 2021 | 1.27 Mn |
| Mar 31, 2021 | 197,570.00 |
| Dec 31, 2020 | 542,927.00 |
| Mar 31, 2020 | 180,342.00 |
| Dec 31, 2019 | 878,728.00 |
| Mar 31, 2019 | 315,321.00 |
| Dec 31, 2018 | 813,190.00 |
| Mar 31, 2018 | 139,853.00 |
| Dec 31, 2017 | 145,336.00 |
| Mar 31, 2017 | 48,932.00 |
| Dec 31, 2016 | 208,558.00 |
| Mar 31, 2016 | 68,324.00 |
| Dec 31, 2015 | 347,756.00 |
| Mar 31, 2015 | 74,169.00 |
| Dec 31, 2014 | 287,498.00 |
| Mar 31, 2013 | 118,073.00 |
| Dec 31, 2012 | 437,427.00 |
| Mar 31, 2012 | 69,001.00 |
| Dec 31, 2011 | 592,085.00 |